Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director Anna Marrs sold 548 shares of Docusign stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $67.00, for a total transaction of $36,716.00. Following the transaction, the director directly owned 13,525 shares of the company’s stock, valued at approximately $906,175. This represents a 3.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Docusign Trading Up 0.3%
Shares of NASDAQ:DOCU opened at $70.64 on Friday. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $86.65. The company has a market capitalization of $13.20 billion, a price-to-earnings ratio of 43.07, a PEG ratio of 2.65 and a beta of 0.90. The firm’s 50-day moving average is $59.60 and its 200 day moving average is $51.41.
Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The business had revenue of $875.75 million during the quarter, compared to the consensus estimate of $867.22 million. During the same quarter last year, the firm earned $0.30 earnings per share. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. As a group, equities analysts forecast that Docusign Inc. will post 2.1 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
A number of research firms recently issued reports on DOCU. Wall Street Zen cut Docusign from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 2nd. Jefferies Financial Group increased their target price on Docusign from $45.00 to $50.00 and gave the stock a “hold” rating in a research note on Friday, June 5th. Morgan Stanley lifted their target price on Docusign from $69.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, September 4th. BTIG Research lifted their target price on Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Finally, Wedbush cut their price target on shares of Docusign from $60.00 to $58.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $67.33.
Get Our Latest Research Report on Docusign
Trending Headlines about Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Customer expansion, increasing IAM adoption and stronger cash flow are supporting the recent rally. Investors view IAM as a potential driver of higher-value software sales and broader customer engagement. Can DOCU Extend Its 13.4% Gain as IAM Momentum Builds?
- Positive Sentiment: Docusign’s latest quarterly results exceeded expectations, with revenue of $875.75 million, adjusted EPS of $1.16 versus a $1.09 consensus estimate, and 9.4% year-over-year revenue growth. The improved earnings outlook is reinforcing the bullish case. Docusign Stock and IAM Growth
- Positive Sentiment: Analysts have raised price targets as Docusign’s AI and IAM strategy gains attention, while the company’s large share-repurchase program may support EPS and shareholder returns. These factors are helping sustain investor interest after the recent advance.
- Neutral Sentiment: Director Mary Agnes Wilderotter sold 1,096 shares for approximately $77,378, and Director Anna Marrs sold 548 shares for about $36,716. Both transactions were made under pre-arranged Rule 10b5-1 plans, reducing their significance as indicators of management sentiment. SEC Insider Trading Filing
- Negative Sentiment: Liquidity concerns, pricing pressure and the need to convert IAM adoption into sustained revenue growth remain risks. Docusign also trades at roughly 43 times earnings, while the overall analyst consensus remains “Hold,” potentially limiting near-term upside after the rally. Is Docusign Stock Worth Buying as IAM Growth Meets Liquidity Risks?
About Docusign
DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.
The company’s products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.
Featured Stories
- Five stocks we like better than Docusign
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
